Livzon Pharmaceutical Group Inc.

General ticker "LVZPF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $4.6B (TTM average)

Livzon Pharmaceutical Group Inc. follows the US Stock Market performance with the rate: 5.2%.

Estimated limits based on current volatility of 0.0%: low 5.22$, high 5.22$

Factors to consider:

  • Company pays dividends (annually): last record date 2026-06-17, amount 0.21$ (Y4.02%)
  • Earnings for 18 months up through Q2 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.94$, 4.80$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.12$, 5.07$]

Financial Metrics affecting the LVZPF estimates:

  • Positive: with PPE of 11.3 at the end of fiscal year the price was low
  • Positive: 22.58 < Operating profit margin, % of 24.08
  • Positive: 11.37 < Operating cash flow per share per price, % of 12.94
  • Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 8.61
  • Positive: Industry inventory ratio change (median), % of -1.31 <= -0.92
  • Positive: 49.86 < Shareholder equity ratio, % of 56.68 <= 58.56
  • Positive: Interest expense per share per price, % of 0.38 <= 0.75
  • Positive: Inventory ratio change, % of 0.36 <= 0.41

Similar symbols

Short-term LVZPF quotes

Long-term LVZPF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue CNY12,629.58MM CNY12,430.04MM CNY11,812.34MM
Operating Expenses CNY10,279.02MM CNY10,014.93MM CNY8,967.94MM
Operating Income CNY2,350.56MM CNY2,415.11MM CNY2,844.40MM
Non-Operating Income CNY-20.01MM CNY-32.44MM CNY-38.25MM
Interest Expense CNY97.55MM CNY102.09MM CNY88.61MM
R&D Expense CNY1,426.52MM CNY1,334.70MM CNY1,033.36MM
Income(Loss) CNY2,330.55MM CNY2,382.67MM CNY2,806.15MM
Taxes CNY375.01MM CNY485.07MM CNY501.66MM
Net Income(Loss)* CNY1,909.41MM CNY1,953.65MM CNY2,061.10MM
Stockholders Equity CNY13,876.02MM CNY14,042.50MM CNY13,862.33MM
Inventory CNY2,045.34MM CNY2,060.65MM CNY1,997.64MM
Assets CNY24,864.83MM CNY25,044.83MM CNY24,455.83MM
Operating Cash Flow CNY2,772.67MM CNY3,394.20MM CNY2,978.85MM
Capital expenditure CNY940.15MM CNY820.45MM CNY570.16MM
Investing Cash Flow CNY-1,229.87MM CNY-777.11MM CNY-660.33MM
Financing Cash Flow CNY-720.36MM CNY-1,733.41MM CNY-2,485.88MM
Earnings Per Share** CNY2.04 CNY2.10 CNY2.24

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.